US Stock MarketDetailed Quotes

AKRO Akero Therapeutics

Watchlist
  • 20.730
  • -0.340-1.61%
Close May 16 16:00 ET
1.43BMarket Cap-6398P/E (TTM)

Akero Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
108.51%59.95M
50.12%172.87M
143.40%61.87M
29.16%46.62M
29.12%35.63M
10.37%28.75M
14.14%115.16M
-21.64%25.42M
48.20%36.09M
-4.74%27.59M
Selling and administrative expenses
33.56%9.3M
4.02%31.07M
19.45%8.48M
-27.47%7.98M
22.68%7.64M
25.81%6.97M
56.18%29.87M
50.17%7.1M
125.35%11M
24.87%6.23M
-General and administrative expense
33.56%9.3M
4.02%31.07M
19.45%8.48M
-27.47%7.98M
22.68%7.64M
25.81%6.97M
56.18%29.87M
50.17%7.1M
125.35%11M
24.87%6.23M
Research and development costs
132.48%50.65M
66.27%141.8M
191.44%53.39M
54.00%38.63M
31.00%27.99M
6.21%21.79M
4.31%85.28M
-33.89%18.32M
28.85%25.09M
-10.90%21.36M
Operating profit
-108.51%-59.95M
-50.12%-172.87M
-143.40%-61.87M
-29.16%-46.62M
-29.12%-35.63M
-10.37%-28.75M
-14.14%-115.16M
21.64%-25.42M
-48.20%-36.09M
4.74%-27.59M
Net non-operating interest income expense
126.21%6.61M
575.98%21.11M
566.09%23.31M
-174.07%-888K
-1,516.98%-857K
13,181.82%2.92M
2,765.14%3.12M
3,111.01%3.5M
-324K
-53K
Non-operating interest income
124.95%7.6M
526.88%24.21M
----
----
----
15,259.09%3.38M
3,443.12%3.86M
----
----
----
Non-operating interest expense
116.85%991K
319.35%3.1M
147.79%897K
174.07%888K
1,516.98%857K
--457K
--739K
--362K
--324K
--53K
Other net income (expense)
798.51%7.84M
2,114.34%5.4M
3,695.65%873K
639.39%244K
Other non- operating income (expenses)
----
----
----
798.51%7.84M
2,114.34%5.4M
----
----
----
3,695.65%873K
639.39%244K
Income before tax
-106.51%-53.34M
-35.46%-151.76M
-139.33%-55.19M
-11.58%-39.66M
-13.43%-31.08M
0.76%-25.83M
-11.17%-112.03M
28.88%-23.06M
-46.08%-35.54M
5.29%-27.4M
Income tax
Net income
-106.51%-53.34M
-35.46%-151.76M
-139.33%-55.19M
-11.58%-39.66M
-13.43%-31.08M
0.76%-25.83M
-11.17%-112.03M
28.88%-23.06M
-46.08%-35.54M
5.29%-27.4M
Net income continuous Operations
-106.51%-53.34M
-35.46%-151.76M
-139.33%-55.19M
-11.58%-39.66M
-13.43%-31.08M
0.76%-25.83M
-11.17%-112.03M
28.88%-23.06M
-46.08%-35.54M
5.29%-27.4M
Minority interest income
Net income attributable to the parent company
-106.51%-53.34M
-35.46%-151.76M
-139.33%-55.19M
-11.58%-39.66M
-13.43%-31.08M
0.76%-25.83M
-11.17%-112.03M
28.88%-23.06M
-46.08%-35.54M
5.29%-27.4M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-106.51%-53.34M
-35.46%-151.76M
-139.33%-55.19M
-11.58%-39.66M
-13.43%-31.08M
0.76%-25.83M
-11.17%-112.03M
28.88%-23.06M
-46.08%-35.54M
5.29%-27.4M
Basic earnings per share
-63.64%-0.9
-0.70%-2.89
-108.16%-1.02
22.83%-0.71
22.08%-0.6
25.68%-0.55
0.69%-2.87
47.31%-0.49
-31.43%-0.92
7.23%-0.77
Diluted earnings per share
-63.64%-0.9
-0.70%-2.89
-108.16%-1.02
22.83%-0.71
22.08%-0.6
25.68%-0.55
0.69%-2.87
47.31%-0.49
-31.43%-0.92
7.23%-0.77
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 108.51%59.95M50.12%172.87M143.40%61.87M29.16%46.62M29.12%35.63M10.37%28.75M14.14%115.16M-21.64%25.42M48.20%36.09M-4.74%27.59M
Selling and administrative expenses 33.56%9.3M4.02%31.07M19.45%8.48M-27.47%7.98M22.68%7.64M25.81%6.97M56.18%29.87M50.17%7.1M125.35%11M24.87%6.23M
-General and administrative expense 33.56%9.3M4.02%31.07M19.45%8.48M-27.47%7.98M22.68%7.64M25.81%6.97M56.18%29.87M50.17%7.1M125.35%11M24.87%6.23M
Research and development costs 132.48%50.65M66.27%141.8M191.44%53.39M54.00%38.63M31.00%27.99M6.21%21.79M4.31%85.28M-33.89%18.32M28.85%25.09M-10.90%21.36M
Operating profit -108.51%-59.95M-50.12%-172.87M-143.40%-61.87M-29.16%-46.62M-29.12%-35.63M-10.37%-28.75M-14.14%-115.16M21.64%-25.42M-48.20%-36.09M4.74%-27.59M
Net non-operating interest income expense 126.21%6.61M575.98%21.11M566.09%23.31M-174.07%-888K-1,516.98%-857K13,181.82%2.92M2,765.14%3.12M3,111.01%3.5M-324K-53K
Non-operating interest income 124.95%7.6M526.88%24.21M------------15,259.09%3.38M3,443.12%3.86M------------
Non-operating interest expense 116.85%991K319.35%3.1M147.79%897K174.07%888K1,516.98%857K--457K--739K--362K--324K--53K
Other net income (expense) 798.51%7.84M2,114.34%5.4M3,695.65%873K639.39%244K
Other non- operating income (expenses) ------------798.51%7.84M2,114.34%5.4M------------3,695.65%873K639.39%244K
Income before tax -106.51%-53.34M-35.46%-151.76M-139.33%-55.19M-11.58%-39.66M-13.43%-31.08M0.76%-25.83M-11.17%-112.03M28.88%-23.06M-46.08%-35.54M5.29%-27.4M
Income tax
Net income -106.51%-53.34M-35.46%-151.76M-139.33%-55.19M-11.58%-39.66M-13.43%-31.08M0.76%-25.83M-11.17%-112.03M28.88%-23.06M-46.08%-35.54M5.29%-27.4M
Net income continuous Operations -106.51%-53.34M-35.46%-151.76M-139.33%-55.19M-11.58%-39.66M-13.43%-31.08M0.76%-25.83M-11.17%-112.03M28.88%-23.06M-46.08%-35.54M5.29%-27.4M
Minority interest income
Net income attributable to the parent company -106.51%-53.34M-35.46%-151.76M-139.33%-55.19M-11.58%-39.66M-13.43%-31.08M0.76%-25.83M-11.17%-112.03M28.88%-23.06M-46.08%-35.54M5.29%-27.4M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -106.51%-53.34M-35.46%-151.76M-139.33%-55.19M-11.58%-39.66M-13.43%-31.08M0.76%-25.83M-11.17%-112.03M28.88%-23.06M-46.08%-35.54M5.29%-27.4M
Basic earnings per share -63.64%-0.9-0.70%-2.89-108.16%-1.0222.83%-0.7122.08%-0.625.68%-0.550.69%-2.8747.31%-0.49-31.43%-0.927.23%-0.77
Diluted earnings per share -63.64%-0.9-0.70%-2.89-108.16%-1.0222.83%-0.7122.08%-0.625.68%-0.550.69%-2.8747.31%-0.49-31.43%-0.927.23%-0.77
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg